Trials / Unknown
UnknownNCT02969096
Clinical Study of Targeted Cryoablation Therapy in the Treatment of Hepatic Carcinoma
Evaluating the Safety and Efficacy of Targeted Cryoablation Therapy in the Treatment of Hepatic Carcinoma
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Shanghai University of Traditional Chinese Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of targeted cryoablation therapy for hepatic carcinoma.
Detailed description
A cryoprobe is inserted percutaneously under CT guidance into the targeted lesion. Patients undergo ablation using a freeze-thaw-freeze cycle lasting approximately 10-6-10minutes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Targeted Cryoablation Therapy | A cryoprobe is inserted percutaneously under CT guidance into the targeted lesion. Patients undergo ablation using a freeze-thaw-freeze cycle lasting approximately 6-10-6 or 8-10-8 minutes, respectively. |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2016-11-21
- Last updated
- 2016-11-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02969096. Inclusion in this directory is not an endorsement.